TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 28.95
+0.55 (1.94%)
Aug 19, 2026, 1:19 PM CST
TWi Biotechnology Market Cap
TWi Biotechnology has a market cap or net worth of 5.84 billion as of August 18, 2026. Its market cap has increased by 190.86% in one year.
Market Cap
5.84B
Enterprise Value
5.73B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
28.95
ChartMarket Cap Chart
Since December 27, 2016, TWi Biotechnology's market cap has increased from 3.83B to 5.84B, an increase of 52.52%. That is a compound annual growth rate of 4.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 5.53B | 205.84% |
| Dec 31, 2025 | 1.81B | 47.88% |
| Dec 31, 2024 | 1.22B | -0.52% |
| Dec 29, 2023 | 1.23B | 22.02% |
| Dec 30, 2022 | 1.01B | -7.50% |
| Dec 30, 2021 | 1.09B | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 7.23B |
| Acepodia | 6.91B |
| Savior Lifetec | 6.35B |
| TaiGen Biopharmaceuticals Holdings | 6.29B |
| Sinphar Pharmaceutical | 6.04B |
| Steminent Biotherapeutics | 5.27B |
| AnnJi Pharmaceutical | 5.16B |
| Mycenax Biotech | 5.08B |